Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-17

Clinical Trial Update: The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study) [NA]

View source ↗

Summary

The LTX-Stent Study investigating the influence of cirrhosis of the liver on coronary restenosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: RWTH Aachen University | Conditions: Re-stenosis, Cirrhosis of the Liver | NA | Status: WITHDRAWN